Search clinical trials for: ChAdOx1-S vaccine

Total 8153 results

Vaxxinity, Inc.
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

COVID-19 Vaccines

Philippines, United States, Panama
Fundação de Medicina Tropical Dr. Heitor Vieira...
Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM); XP Investimentos and other collaborators

Active, not recruiting

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity (COVACManaus2)

Healthy | Comorbidities and Coexisting Conditions

Brazil
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
Hospital Moinhos de Vento
Pfizer; Universidade Federal do Paraná; Inova Medical

Completed

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

Covid19

Brazil
AstraZeneca

Completed

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study (REFORCO-B)

COVID-19

Brazil
R-Pharm
AstraZeneca

Completed

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

COVID-19

United Arab Emirates
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

SARS-CoV-2 Infection

Mexico
University of Oxford

Active, not recruiting

Investigating a Vaccine Against COVID-19

Coronavirus

United Kingdom
D'Or Institute for Research and Education
Bill and Melinda Gates Foundation; Instituto Fernandes Figueira

Not yet recruiting

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) (TP-SCB-2019001)

Covid19

Brazil
Mahidol University
Clinixir Co., Ltd.; Program Management Unit-C (PMU-C), governed by Ministry...

Completed

Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine

COVID-19 Infection | COVID-19 VACCINE

Thailand
University of Oxford

Active, not recruiting

A Study of a Candidate COVID-19 Vaccine (COV001)

Coronavirus

United Kingdom
Assiut University

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine

Egypt
Chimei Medical Center

Completed

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population

Taiwan
R-Pharm
AstraZeneca; Russian Direct Investment Fund; The Gamaleya National Center of...

Completed

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

COVID-19

Azerbaijan
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz

Recruiting

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

SARS-CoV-2 Infection

Brazil
Italian Group for the study of Inflammatory Bowel...

Unknown

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD) (ESCAPE-IBD)

Inflammatory Bowel Diseases
Korea University Guro Hospital
Ajou University School of Medicine; Korean Center for Disease Control and Prevention and other collaborators

Recruiting

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Inflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 Vaccination

Korea, Republic of
Universidad del Desarrollo
Pontificia Universidad Catolica de Chile; University of Chile; Ministry of Health...

Active, not recruiting

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster (REFUERZO)

Covid19

Chile
Canadian Immunization Research Network
Massachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaborators

Active, not recruiting

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity (MOSAIC)

COVID-19

Canada
Adimmune Corporation

Completed

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

Influenza

Taiwan
Medical University of Vienna

Active, not recruiting

Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients (BOOST_TX)

COVID-19

Austria
University of Oxford

Active, not recruiting

Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Rabies

United Kingdom
University of Oxford
Ifakara Health Institute

Active, not recruiting

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Rabies

Tanzania
GlaxoSmithKline

Completed

A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Shigella Sonnei Infection

Kenya
Federal University of Espirito Santo
Centro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito...

Not yet recruiting

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly (Plus_Booster)

COVID-19 | Vaccine Adverse Reaction | Vaccine-Preventable Diseases

Brazil
GlaxoSmithKline

Completed

Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.

Malaria

Kenya, Tanzania
Universiteit Antwerpen

Completed

Immunogenicity After COVID-19 Vaccines in Adapted Schedules (IMCOVAS)

COVID-19 | Coronavirus Disease 2019

Belgium
Chinese Academy of Sciences
Jiangsu Province Centers for Disease Control and Prevention; Hualan Biological...

Unknown

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Human Influenza

China
Ministry of Public Health, Argentina
Russian Direct Investment Fund

Recruiting

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina (ECEHeVac)

Covid19 | COVID-19 VACCINE

Argentina
Umeå University

Not yet recruiting

Risk of COVID-19 Infection After Vaccination

Covid19 | Vaccination; Infection
National Taiwan University Hospital
Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Completed

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Healthy Adult Volunteers

Taiwan
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Dysentery, Bacillary

United States
GlaxoSmithKline

Completed

Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

Malaria

Ghana
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; IPPOX Foundation; Center for HIV/AIDS Vaccine Immunology...

Withdrawn

Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults

HIV Infections
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
Binhui Biopharmaceutical Co., Ltd.

Recruiting

Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

COVID-19

China
François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
National Taiwan University Hospital

Unknown

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Serology Analysis | Novel H1N1 Influenza Vaccination | Pediatric Haemato-oncology Patients

Taiwan
KEMRI-Wellcome Trust Collaborative Research Program
GlaxoSmithKline

Unknown

An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial (MAL059)

Malaria

Kenya
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
University of Oxford

Enrolling by invitation

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients (CVTB)

Tuberculosis | Covid-19 Pandemics

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.

Plasmodium Falciparum

Kenya
SK Bioscience Co., Ltd.
GlaxoSmithKline; International Vaccine Institute; Coalition for Epidemic Preparedness...

Completed

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

Covid19

Thailand, Korea, Republic of, New Zealand, Philippines, Ukraine, Vietnam
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Shigellosis | Dysentery

China
ANRS, Emerging Infectious Diseases
LinKinVax; Vaccine Research Institute (VRI), France

Not yet recruiting

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

COVID-19
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device

Influenza Infection

China
Pfizer

Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

HIV Infections | Pneumococcal Infections

South Africa, Romania
National Institute of Allergy and Infectious Diseases...

Completed

ACAM 3000 MVA at Harvard Medical School

Smallpox

United States

Search clinical trials for: ChAdOx1-S vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations